Establishing Mixed Neuronal and Glial Cell Cultures from Embryonic Mouse Brains to Study Infection and Innate Immunity.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
30 06 2023
Historique:
medline: 19 7 2023
pubmed: 17 7 2023
entrez: 17 7 2023
Statut: epublish

Résumé

Models of the central nervous system (CNS) must recapitulate the complex network of interconnected cells found in vivo. The CNS consists primarily of neurons, astrocytes, oligodendrocytes, and microglia. Due to increasing efforts to replace and reduce animal use, a variety of in vitro cell culture systems have been developed to explore innate cell properties, which allow the development of therapeutics for CNS infections and pathologies. Whilst certain research questions can be addressed by human-based cell culture systems, such as (induced) pluripotent stem cells, working with human cells has its own limitations with regard to availability, costs, and ethics. Here, we describe a unique protocol for isolating and culturing cells from embryonic mouse brains. The resulting mixed neural cell cultures mimic several cell populations and interactions found in the brain in vivo. Compared to current equivalent methods, this protocol more closely mimics the characteristics of the brain and also garners more cells, thus allowing for more experimental conditions to be investigated from one pregnant mouse. Further, the protocol is relatively easy and highly reproducible. These cultures have been optimized for use at various scales, including 96-well based high throughput screens, 24-well microscopy analysis, and 6-well cultures for flow cytometry and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis. This culture method is a powerful tool to investigate infection and immunity within the context of some of the complexity of the CNS with the convenience of in vitro methods.

Identifiants

pubmed: 37458443
doi: 10.3791/65331
doi:

Types de publication

Journal Article Video-Audio Media Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 217093/Z/19/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MRV0109721
Pays : United Kingdom

Auteurs

Alistair Gamble (A)

School of Infection and Immunity, University of Glasgow.

Maria Suessmilch (M)

School of Infection and Immunity, University of Glasgow.

Anniek Bonestroo (A)

School of Infection and Immunity, University of Glasgow.

Andres Merits (A)

Faculty of Science and Technology, Institute of Technology, University of Tartu.

Gerard J Graham (GJ)

School of Infection and Immunity, University of Glasgow.

Jonathan Cavanagh (J)

School of Infection and Immunity, University of Glasgow.

Julia M Edgar (JM)

School of Infection and Immunity, University of Glasgow.

Marieke Pingen (M)

School of Infection and Immunity, University of Glasgow; marieke.pingen@glasgow.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH